GO:0003747 | translation release factor activity | 1.64e-06 | 1.60e-02 | 9.553 | 2 | 2 | 2 |
GO:0006479 | protein methylation | 8.94e-05 | 8.73e-01 | 7.094 | 2 | 2 | 11 |
GO:0006383 | transcription from RNA polymerase III promoter | 6.51e-04 | 1.00e+00 | 5.695 | 2 | 6 | 29 |
GO:0016149 | translation release factor activity, codon specific | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0005643 | nuclear pore | 2.01e-03 | 1.00e+00 | 4.881 | 2 | 12 | 51 |
GO:0035928 | rRNA import into mitochondrion | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0008097 | 5S rRNA binding | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0006415 | translational termination | 3.05e-03 | 1.00e+00 | 4.576 | 2 | 2 | 63 |
GO:0001649 | osteoblast differentiation | 4.19e-03 | 1.00e+00 | 4.344 | 2 | 5 | 74 |
GO:0097452 | GAIT complex | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 2 | 4 |
GO:0006449 | regulation of translational termination | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 5.36e-03 | 1.00e+00 | 4.161 | 2 | 5 | 84 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 3 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0060744 | mammary gland branching involved in thelarche | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0000127 | transcription factor TFIIIC complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 3 | 5 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 3 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 6 |
GO:0001055 | RNA polymerase II activity | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 3 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 6 |
GO:0005739 | mitochondrion | 8.99e-03 | 1.00e+00 | 2.189 | 4 | 32 | 659 |
GO:0002199 | zona pellucida receptor complex | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 4 | 7 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 2 | 7 |
GO:0005832 | chaperonin-containing T-complex | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 4 | 7 |
GO:0051292 | nuclear pore complex assembly | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 4 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 4 | 8 |
GO:0017056 | structural constituent of nuclear pore | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 3 | 8 |
GO:0071354 | cellular response to interleukin-6 | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 9 |
GO:0000398 | mRNA splicing, via spliceosome | 1.21e-02 | 1.00e+00 | 3.553 | 2 | 15 | 128 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 10 |
GO:0008143 | poly(A) binding | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 2 | 10 |
GO:0001054 | RNA polymerase I activity | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 4 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 4 | 11 |
GO:0004527 | exonuclease activity | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 4 | 12 |
GO:0034399 | nuclear periphery | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 3 | 12 |
GO:0006336 | DNA replication-independent nucleosome assembly | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 2 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0060749 | mammary gland alveolus development | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 1 | 13 |
GO:0016032 | viral process | 1.72e-02 | 1.00e+00 | 2.396 | 3 | 30 | 428 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 2 | 13 |
GO:0044822 | poly(A) RNA binding | 1.75e-02 | 1.00e+00 | 1.911 | 4 | 45 | 799 |
GO:0006386 | termination of RNA polymerase III transcription | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 3 | 14 |
GO:0016575 | histone deacetylation | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 14 |
GO:0008380 | RNA splicing | 1.96e-02 | 1.00e+00 | 3.187 | 2 | 21 | 165 |
GO:0000188 | inactivation of MAPK activity | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 4 | 15 |
GO:0043022 | ribosome binding | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 2 | 17 |
GO:0006412 | translation | 2.26e-02 | 1.00e+00 | 3.077 | 2 | 12 | 178 |
GO:0005654 | nucleoplasm | 2.38e-02 | 1.00e+00 | 1.778 | 4 | 68 | 876 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 3 | 20 |
GO:0005761 | mitochondrial ribosome | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 1 | 20 |
GO:0071346 | cellular response to interferon-gamma | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 2 | 20 |
GO:0005743 | mitochondrial inner membrane | 2.73e-02 | 1.00e+00 | 2.931 | 2 | 9 | 197 |
GO:0008536 | Ran GTPase binding | 2.76e-02 | 1.00e+00 | 5.161 | 1 | 1 | 21 |
GO:0006363 | termination of RNA polymerase I transcription | 2.76e-02 | 1.00e+00 | 5.161 | 1 | 3 | 21 |
GO:0015031 | protein transport | 2.89e-02 | 1.00e+00 | 2.888 | 2 | 10 | 203 |
GO:0030331 | estrogen receptor binding | 2.89e-02 | 1.00e+00 | 5.094 | 1 | 2 | 22 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.89e-02 | 1.00e+00 | 5.094 | 1 | 4 | 22 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 2 | 23 |
GO:0043234 | protein complex | 3.07e-02 | 1.00e+00 | 2.839 | 2 | 13 | 210 |
GO:0010467 | gene expression | 3.10e-02 | 1.00e+00 | 2.075 | 3 | 49 | 535 |
GO:0006370 | 7-methylguanosine mRNA capping | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 6 | 24 |
GO:0010827 | regulation of glucose transport | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 7 | 25 |
GO:0006360 | transcription from RNA polymerase I promoter | 3.54e-02 | 1.00e+00 | 4.798 | 1 | 4 | 27 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 4.05e-02 | 1.00e+00 | 4.599 | 1 | 6 | 31 |
GO:0003723 | RNA binding | 4.14e-02 | 1.00e+00 | 2.605 | 2 | 22 | 247 |
GO:0007077 | mitotic nuclear envelope disassembly | 4.18e-02 | 1.00e+00 | 4.553 | 1 | 9 | 32 |
GO:0017148 | negative regulation of translation | 4.31e-02 | 1.00e+00 | 4.509 | 1 | 5 | 33 |
GO:0035914 | skeletal muscle cell differentiation | 4.31e-02 | 1.00e+00 | 4.509 | 1 | 3 | 33 |
GO:0007254 | JNK cascade | 4.44e-02 | 1.00e+00 | 4.466 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 5 | 35 |
GO:0044297 | cell body | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 5 | 35 |
GO:0008645 | hexose transport | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 8 | 36 |
GO:0006396 | RNA processing | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 6 | 40 |
GO:0051028 | mRNA transport | 6.08e-02 | 1.00e+00 | 3.998 | 1 | 5 | 47 |
GO:0032481 | positive regulation of type I interferon production | 6.21e-02 | 1.00e+00 | 3.968 | 1 | 3 | 48 |
GO:0015758 | glucose transport | 6.21e-02 | 1.00e+00 | 3.968 | 1 | 8 | 48 |
GO:0045892 | negative regulation of transcription, DNA-templated | 6.47e-02 | 1.00e+00 | 2.245 | 2 | 17 | 317 |
GO:0016020 | membrane | 6.65e-02 | 1.00e+00 | 1.316 | 4 | 56 | 1207 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 6.71e-02 | 1.00e+00 | 3.853 | 1 | 8 | 52 |
GO:0006289 | nucleotide-excision repair | 6.83e-02 | 1.00e+00 | 3.825 | 1 | 6 | 53 |
GO:0042826 | histone deacetylase binding | 7.46e-02 | 1.00e+00 | 3.695 | 1 | 5 | 58 |
GO:0044267 | cellular protein metabolic process | 7.78e-02 | 1.00e+00 | 2.094 | 2 | 14 | 352 |
GO:0071013 | catalytic step 2 spliceosome | 7.83e-02 | 1.00e+00 | 3.622 | 1 | 5 | 61 |
GO:0030308 | negative regulation of cell growth | 8.93e-02 | 1.00e+00 | 3.424 | 1 | 3 | 70 |
GO:0051082 | unfolded protein binding | 8.93e-02 | 1.00e+00 | 3.424 | 1 | 5 | 70 |
GO:0016363 | nuclear matrix | 9.30e-02 | 1.00e+00 | 3.363 | 1 | 10 | 73 |
GO:0030529 | ribonucleoprotein complex | 1.04e-01 | 1.00e+00 | 3.195 | 1 | 5 | 82 |
GO:0005635 | nuclear envelope | 1.05e-01 | 1.00e+00 | 3.178 | 1 | 6 | 83 |
GO:0006886 | intracellular protein transport | 1.12e-01 | 1.00e+00 | 3.077 | 1 | 2 | 89 |
GO:0006457 | protein folding | 1.22e-01 | 1.00e+00 | 2.953 | 1 | 5 | 97 |
GO:0005515 | protein binding | 1.30e-01 | 1.00e+00 | 0.543 | 8 | 198 | 4124 |
GO:0003735 | structural constituent of ribosome | 1.36e-01 | 1.00e+00 | 2.785 | 1 | 2 | 109 |
GO:0000790 | nuclear chromatin | 1.36e-01 | 1.00e+00 | 2.785 | 1 | 9 | 109 |
GO:0042981 | regulation of apoptotic process | 1.39e-01 | 1.00e+00 | 2.746 | 1 | 4 | 112 |
GO:0007049 | cell cycle | 1.43e-01 | 1.00e+00 | 2.707 | 1 | 8 | 115 |
GO:0003924 | GTPase activity | 1.47e-01 | 1.00e+00 | 2.658 | 1 | 7 | 119 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.54e-01 | 1.00e+00 | 2.587 | 1 | 4 | 125 |
GO:0031965 | nuclear membrane | 1.60e-01 | 1.00e+00 | 2.531 | 1 | 8 | 130 |
GO:0006184 | GTP catabolic process | 1.60e-01 | 1.00e+00 | 2.531 | 1 | 7 | 130 |
GO:0044212 | transcription regulatory region DNA binding | 1.75e-01 | 1.00e+00 | 2.393 | 1 | 13 | 143 |
GO:0005622 | intracellular | 1.77e-01 | 1.00e+00 | 2.373 | 1 | 2 | 145 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.94e-01 | 1.00e+00 | 2.222 | 1 | 18 | 161 |
GO:0005874 | microtubule | 1.97e-01 | 1.00e+00 | 2.204 | 1 | 10 | 163 |
GO:0016071 | mRNA metabolic process | 2.04e-01 | 1.00e+00 | 2.144 | 1 | 10 | 170 |
GO:0019221 | cytokine-mediated signaling pathway | 2.06e-01 | 1.00e+00 | 2.127 | 1 | 10 | 172 |
GO:0000166 | nucleotide binding | 2.11e-01 | 1.00e+00 | 2.094 | 1 | 13 | 176 |
GO:0005975 | carbohydrate metabolic process | 2.21e-01 | 1.00e+00 | 2.014 | 1 | 10 | 186 |
GO:0016070 | RNA metabolic process | 2.23e-01 | 1.00e+00 | 1.998 | 1 | 10 | 188 |
GO:0005525 | GTP binding | 2.33e-01 | 1.00e+00 | 1.931 | 1 | 12 | 197 |
GO:0005634 | nucleus | 2.39e-01 | 1.00e+00 | 0.473 | 6 | 158 | 3246 |
GO:0006281 | DNA repair | 2.39e-01 | 1.00e+00 | 1.888 | 1 | 24 | 203 |
GO:0006355 | regulation of transcription, DNA-templated | 2.46e-01 | 1.00e+00 | 1.071 | 2 | 31 | 715 |
GO:0019899 | enzyme binding | 2.46e-01 | 1.00e+00 | 1.839 | 1 | 7 | 210 |
GO:0005737 | cytoplasm | 2.58e-01 | 1.00e+00 | 0.512 | 5 | 127 | 2633 |
GO:0008285 | negative regulation of cell proliferation | 3.12e-01 | 1.00e+00 | 1.439 | 1 | 11 | 277 |
GO:0000278 | mitotic cell cycle | 3.46e-01 | 1.00e+00 | 1.258 | 1 | 28 | 314 |
GO:0055085 | transmembrane transport | 3.60e-01 | 1.00e+00 | 1.191 | 1 | 13 | 329 |
GO:0003677 | DNA binding | 3.64e-01 | 1.00e+00 | 0.666 | 2 | 52 | 947 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.70e-01 | 1.00e+00 | 1.139 | 1 | 23 | 341 |
GO:0070062 | extracellular vesicular exosome | 3.77e-01 | 1.00e+00 | 0.458 | 3 | 51 | 1641 |
GO:0042802 | identical protein binding | 3.81e-01 | 1.00e+00 | 1.085 | 1 | 15 | 354 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.01e-01 | 1.00e+00 | 0.995 | 1 | 21 | 377 |
GO:0005783 | endoplasmic reticulum | 4.04e-01 | 1.00e+00 | 0.979 | 1 | 12 | 381 |
GO:0006351 | transcription, DNA-templated | 4.28e-01 | 1.00e+00 | 0.482 | 2 | 47 | 1076 |
GO:0005829 | cytosol | 4.35e-01 | 1.00e+00 | 0.335 | 3 | 88 | 1787 |
GO:0045087 | innate immune response | 4.60e-01 | 1.00e+00 | 0.733 | 1 | 12 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.63e-01 | 1.00e+00 | 0.720 | 1 | 29 | 456 |
GO:0005887 | integral component of plasma membrane | 5.46e-01 | 1.00e+00 | 0.386 | 1 | 8 | 575 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 5.50e-01 | 1.00e+00 | 0.368 | 1 | 22 | 582 |
GO:0007165 | signal transduction | 5.73e-01 | 1.00e+00 | 0.282 | 1 | 24 | 618 |
GO:0005615 | extracellular space | 5.92e-01 | 1.00e+00 | 0.206 | 1 | 15 | 651 |
GO:0044281 | small molecule metabolic process | 6.91e-01 | 1.00e+00 | -0.168 | 1 | 35 | 844 |
GO:0005524 | ATP binding | 7.12e-01 | 1.00e+00 | -0.248 | 1 | 37 | 892 |
GO:0005730 | nucleolus | 8.23e-01 | 1.00e+00 | -0.696 | 1 | 74 | 1217 |